Impact of adherence to key performance indicators on mortality among patients managed for ischemic stroke

ABSTRACT

Background: Stroke is a leading cause of death worldwide. The cases of acute ischemic stroke are on the increase in the Asia Pacific, particularly in Malaysia. Various health organizations have recommended guidelines for managing ischemic stroke, but adherence to key performance indicators (KPI) from the guidelines and impact on patient outcomes, particularly mortality, are rarely explored. Objective: This study aims to evaluate the impact of adherence to key performance indicators on mortality among patients managed for ischemic stroke. Methods: We included all first-ever ischemic stroke patients enrolled in the multiethnic Malaysian National Neurology Registry (NNeuR) - a prospective cohort study and followed-up for six months. Patients’ baseline clinical characteristics, risk factors, neurological findings, treatments, KPI and mortality outcome were evaluated. The KPI nonadherence (NAR) and relationship with mortality were evaluated. NAR>25% threshold was considered suboptimal. Results: A total of 579 first-ever ischemic stroke patients were included in the final analysis. The overall mortality was recorded as 23 (4.0%) in six months, with a median (interquartile) age of 65 (20) years. Majority of the patients (dead or alive) had partial anterior circulation infarct, PACI (43.5%; 34.0%) and total anterior circulation infarct, TACI (26.1%; 8.8%). In addition, DVT prophylaxis (82.8%), anticoagulant for atrial fibrillation (AF) patients (48.8%) and rehabilitation (26.2%) were considered suboptimal. NAR < 2 was significantly associated with a decrease in mortality (odds ratio 0.16; 0.02-0.12) compared to NAR>2. Survival analysis showed that death is more likely in patients with NAR>2 (p=0.05). Conclusions: KPI nonadherence was associated with mortality among ischemic stroke patients. The adherence to the KPI was suboptimal, particularly in DVT prophylaxis, anticoagulant for AF patients and rehabilitation. These findings reflect the importance of continuous quality measurement and implementation of evidence recommendations in healthcare delivery to achieve optimal outcome among stroke patients.

KEYWORDS

• Stroke
• Brain Ischemia
• Risk Factors
• Anticoagulants
• Guideline Adherence
• Professional Practice
• Mortality
• Registries
• Prospective Studies
• Survival Analysis
• Malaysia

Showing references and in-text citations exactly as published.

• DOI10.18549/PharmPract.2020.1.1760Copy

RELATED ARTICLES

Matched on section and article type within this issue of PP.

• Article · VOLUME 18, ISSUE 1Community pharmacists’ recommendations for natural products for stress in Melbourne, Australia: a simulated patient studyKevin Clayton, Yoni Luxford, Joshua Colaci, Meral Hasan, Rebecca Miltiadou, Daria Novikova, Dean Vlahopoulos, Ieva Stupans · pp. 1660Original ResearchSame type: Article
• Article · VOLUME 18, ISSUE 1Differences between pharmacists’ perception of counseling and practice in the era of prescription drug misuseJ. Douglas Thornton, Precious Anyanwu, Vaishnavi Tata, Tamara Al-Rawwad, Marc L. Fleming · pp. 1682Original ResearchSame type: Article
• Article · VOLUME 18, ISSUE 1Evaluation of discharge instructions among hospitalized Lebanese patientsMirella Fares, Dalia Khachman, Pascale Salameh, Nathalie Lahoud · pp. 1686Original ResearchSame type: Article
• Article · VOLUME 18, ISSUE 1A naturalistic observation study of medication counseling practices at retail chain pharmaciesSoham D. Yande, Prajakta P. Masurkar, Suma Gopinathan, Sujit S. Sansgiry · pp. 1696Original ResearchSame type: Article